United Therapeutics Corporation logo

United Therapeutics Corporation

UTHR | NASDAQ
Chart Builder DCF Calculator
$493.10
-$1.53 (-0.31%)
At close: Sep 21, 2026, 4:00 PM ET
$500
+$6.90 (+1.40%)
Pre-market: Sep 22, 2026, 8:55 AM ET
Fiscal Quarter
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Revenue
783.3M 781.5M 790.2M 799.5M 798.6M 794.4M 735.9M 748.9M 714.9M 677.7M 614.7M 609.4M 596.5M 506.9M 491.5M 516M 466.9M 461.9M 415.2M 444.7M 446.5M 379.1M
Cost of Revenue
99.5M 133.4M 103.4M 100.9M 87.6M 92.5M 75.9M 83.1M 77.8M 72.9M 71M 70.1M 64.1M 52.3M 55.9M 37.2M 29.7M 25.9M 34.6M 27.7M 37.2M 23M
Gross Profit
683.8M 648.1M 686.8M 698.6M 711M 701.9M 660M 665.8M 637.1M 604.8M 543.7M 539.3M 532.4M 454.6M 435.6M 478.8M 437.2M 436M 380.6M 417M 409.3M 356.1M
Operating Income
330.8M 325.8M 357.5M 389.3M 364.5M 382.8M 357.7M 343.1M 319.9M 356.3M 260.1M 327M 313.4M 284.4M 175.6M 314.3M 201.8M 288M 169.8M 228.7M 222.2M -64.8M
Interest Income
31.5M 41.8M 43.2M 46.4M 51.3M 51.1M 49.3M 49.8M 46.2M 53.8M 51M 45.3M 37.2M 29.2M 20.8M 13.3M 6.8M 4.3M 4.2M 3.8M 4M 4.7M
Pretax Income
372.7M 318.3M 444M 438M 408.4M 423.5M 396.5M 388.6M 355.3M 398.6M 295.4M 351.8M 335.2M 291.9M 178.8M 312.5M 150.6M 308.7M 140.5M 204.4M 216.5M 32.5M
Net Income
333M 274.9M 364.3M 338.7M 309.5M 322.2M 301.3M 309.1M 278.1M 306.6M 217.1M 267.6M 259.2M 240.9M 132.1M 239.3M 116M 239.9M 112.2M 162.7M 172.6M 28.3M
Selling & General & Admin
175.2M 184.1M 189.8M 181.8M 190.8M 170.1M 162.5M 219.2M 177.6M 144.4M 132.2M 127.6M 130M 87.3M 166.1M 98.4M 141.5M 79M 127.9M 109.1M 112.8M 117.2M
Research & Development
146.3M 138.2M 139.5M 127.5M 134M 149M 133.8M 103.5M 139.6M 104.1M 151.4M 84.7M 89M 82.9M 93.9M 66.1M 93.9M 69M 82.9M 79.2M 74.3M 303.7M
Other Expenses
31.5M n/a n/a n/a 21.7M n/a 6M n/a n/a n/a n/a n/a -600K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
353M 322.3M 329.3M 309.3M 346.5M 319.1M 302.3M 322.7M 317.2M 248.5M 283.6M 212.3M 219M 170.2M 260M 164.5M 235.4M 148M 210.8M 188.3M 187.1M 420.9M
Interest Expense
2.9M 3M 3.1M 3M 7.3M 6.1M 7.9M 10.1M 11.6M 13.3M 15.1M 15.6M 14.8M 13.8M 12.3M 9.2M 6.2M 4.7M 4.7M 4.6M 4.7M 4.6M
Selling & Marketing Expenses
37.3M 28.7M 32.7M 28.3M 31M 26.6M 27M 20.7M 25.4M 23.2M 24.1M 20.7M 20.1M 16.9M 23M 17.2M 16.1M 14.5M 16.4M 17.2M 17.1M 13.7M
Cost & Expenses
452.5M 455.7M 432.7M 410.2M 434.1M 411.6M 378.2M 405.8M 395M 321.4M 354.6M 282.4M 283.1M 222.5M 315.9M 201.7M 265.1M 173.9M 245.4M 216M 224.3M 443.9M
Income Tax Expense
39.7M 43.4M 79.7M 99.3M 98.9M 101.3M 95.2M 79.5M 77.2M 92M 78.3M 84.2M 76M 51M 46.7M 73.2M 34.6M 68.8M 28.3M 41.7M 43.9M 4.2M
Shares Outstanding (Basic)
42.6M 43.5M 44.3M 43.8M 45.1M 44.9M 45.2M 44.6M 44.4M 47M 47M 46.9M 46.9M 46.3M 45.8M 48.7M 48.1M 47.69M 45.1M 44.9M 44.8M 44.6M
Shares Outstanding (Diluted)
45.8M 47.2M 47.9M 47.3M 48.3M 48.6M 48.7M 48.4M 47.5M 49.7M 49.8M 49.7M 49.5M 49.6M 49.4M 48.7M 48.1M 47.7M 47.8M 47.6M 47.3M 46.4M
EPS (Basic)
7.82 6.32 8.36 7.73 6.86 7.18 6.74 6.93 6.26 6.52 4.62 5.71 5.53 5.20 2.88 4.91 2.41 5.03 2.49 3.62 3.85 0.63
EPS (Diluted)
7.27 5.82 7.66 7.16 6.41 6.63 6.19 6.39 5.85 6.17 4.36 5.38 5.24 4.86 2.67 4.91 2.41 5.03 2.35 3.42 3.65 0.61
EBITDA
375.6M 343.9M 469.9M 462.9M 436.8M 437.2M 424.1M 417.8M 385.6M 426.9M 324.2M 380.7M 362.9M 319M 198.1M 334.6M 169.5M 325.9M 181.8M 221.4M 233.6M 49.6M
EBIT
375.6M 321.3M 447.1M 441M 415.7M 417.4M 404.4M 398.7M 366.9M 411.9M 310.5M 367.4M 350M 305.7M 184.9M 321.7M 156.8M 313.4M 169.2M 209M 221.2M 37.1M
Depreciation & Amortization
n/a 22.6M 22.8M 21.9M 21.1M 19.8M 19.7M 19.1M 18.7M 15M 13.7M 13.3M 12.9M 13.3M 13.2M 12.9M 12.7M 12.5M 12.6M 12.4M 12.4M 12.5M

© 2026 bestshares.com. All rights reserved.